Last updated on November 2018

Micronized dHACM Injectable for the Treatment of Achille Tendonitis

Brief description of study

Prospective, Double-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to Saline Placebo Injection in the Treatment of Achilles Tendonitis

Detailed Study Description

Approximately 158 subjects will be enrolled in this study. Each patient will receive 1 injection and be evaluated for efficacy and safety during a 12 month observation period. Randomization will be 1:1. The study is expected to be completed in 24 months, inclusive of enrollment and follow-up of all subjects.

Clinical Study Identifier: NCT03414255

Contact Investigators or Research Sites near you

Start Over

Alexis Ley, DPM

University Orthopedics Center
Altoona, PA United States
  Connect »